A citation-based method for searching scientific literature

Edenir I Palmero, Maira Caleffi, Lavínia Schüler-Faccini, Fernanda L Roth, Luciane Kalakun, Cristina Brinkmann Oliveira Netto, Giovana Skonieski, Juliana Giacomazzi, Bernadete Weber, Roberto Giugliani, Suzi A Camey, Patricia Ashton-Prolla. Genet Mol Biol 2009
Times Cited: 15







List of co-cited articles
40 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Maria Isabel Waddington Achatz, Magali Olivier, Florence Le Calvez, Ghyslaine Martel-Planche, Ademar Lopes, Benedito Mauro Rossi, Patricia Ashton-Prolla, Roberto Giugliani, Edenir Inez Palmero, Fernando Regla Vargas,[...]. Cancer Lett 2007
127
33

Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil.
Edenir Inez Palmero, Patricia Ashton-Prolla, José Cláudio C da Rocha, Fernando Regla Vargas, Luciane Kalakun, Melissa Brauner Blom, Sérgio J Azevedo, Maira Caleffi, Roberto Giugliani, Lavinia Schüler-Faccini. J Genet Couns 2007
17
26

Global cancer statistics, 2002.
D Max Parkin, Freddie Bray, J Ferlay, Paola Pisani. CA Cancer J Clin 2005
20

Consistency of self-reported first-degree family history of cancer in a population-based study.
Fernanda Lenara Roth, Suzi Alves Camey, Maira Caleffi, Lavínia Schuler-Faccini, Edenir Inêz Palmero, Carla Bochi, Susana Mayer Moreira, Luciane Kalakun, Roberto Giugliani, Patrícia Ashton-Prolla. Fam Cancer 2009
16
20

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
J M Birch, A L Hartley, K J Tricker, J Prosser, A Condie, A M Kelsey, M Harris, P H Jones, A Binchy, D Crowther. Cancer Res 1994
401
20

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
333
20


Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, Fernanda L Roth, Edenir I Palmero, Luciane Kalakun, Ernestina S Aguiar, Susana M Moreira, Erica Batassini, Vanessa Belo-Reyes,[...]. BMC Cancer 2009
38
20

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
R C Ribeiro, F Sandrini, B Figueiredo, G P Zambetti, E Michalkiewicz, A R Lafferty, L DeLacerda, M Rabin, C Cadwell, G Sampaio,[...]. Proc Natl Acad Sci U S A 2001
339
20

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
Felipe C Silva, Bianca Cg Lisboa, Marcia Cp Figueiredo, Giovana T Torrezan, Erika Mm Santos, Ana C Krepischi, Benedito M Rossi, Maria I Achatz, Dirce M Carraro. BMC Med Genet 2014
39
20

Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.
Gabriela Es Felix, Camila Abe-Sandes, Taísa Mb Machado-Lopes, Thaís F Bomfim, Rodrigo Santa Cruz Guindalini, Vanessa Catarine Sar Santos, Lorena Meyer, Polyanna C Oliveira, João Cláudio Neiva, Roberto Meyer,[...]. Hum Genome Var 2014
22
20

Validity of models for predicting BRCA1 and BRCA2 mutations.
Giovanni Parmigiani, Sining Chen, Edwin S Iversen, Tara M Friebel, Dianne M Finkelstein, Hoda Anton-Culver, Argyrios Ziogas, Barbara L Weber, Andrea Eisen, Kathleen E Malone,[...]. Ann Intern Med 2007
74
13

Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.
E C B da Costa, F R Vargas, A S Moreira, J J Lourenço, M Caleffi, P Ashton-Prolla, M A M Martins Moreira. Cancer Genet Cytogenet 2008
17
13

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
648
13


Germline mutations in the TP53 gene.
R A Eeles. Cancer Surv 1995
144
13

[Increase in breast cancer mortality in Southern Brazil from 1980 to 2002].
Andrea T Cadaval Gonçalves, Paulo Fernandes Costa Jobim, Roberta Vanacor, Luciana Neves Nunes, Isabella Martins de Albuquerque, Mary Clarisse Bozzetti. Cad Saude Publica 2007
15
13

A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988
954
13


The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.
Hanne Meijers-Heijboer, Juul Wijnen, Hans Vasen, Marijke Wasielewski, Anja Wagner, Antoinette Hollestelle, Fons Elstrodt, Renate van den Bos, Anja de Snoo, Grace Tjon A Fat,[...]. Am J Hum Genet 2003
155
13

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
13

A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).
Maira Caleffi, Rodrigo A Ribeiro, Dakir L Duarte Filho, Patrícia Ashton-Prolla, Ademar J Bedin, Giovana P Skonieski, Juliana M Zignani, Juliana Giacomazzi, Luciane R Franco, Márcia Graudenz,[...]. BMC Public Health 2009
20
13

Improved survival in women with BRCA-associated ovarian carcinoma.
Ilana Cass, Rae Lynn Baldwin, Taz Varkey, Roxana Moslehi, Steven A Narod, Beth Y Karlan. Cancer 2003
338
13


Rating the risk factors for breast cancer.
S Eva Singletary. Ann Surg 2003
146
13

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
143
13

Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
Edenir Inêz Palmero, Lavínia Schüler-Faccini, Maira Caleffi, Maria Isabel Waddington Achatz, Magali Olivier, Ghyslaine Martel-Planche, Virginie Marcel, Ernestina Aguiar, Juliana Giacomazzi, Ingrid Petroni Ewald,[...]. Cancer Lett 2008
70
13

Family history of cancer in Brazil: is it being used?
Danilo V Viana, Juvenal R N Góes, Cláudio S R Coy, Maria de Lourdes Setsuko Ayrizono, Carmen S P Lima, Iscia Lopes-Cendes. Fam Cancer 2008
8
25

Hereditary breast cancer: practical pursuit for clinical translation.
Henry T Lynch, Carrie Snyder, Jane Lynch. Ann Surg Oncol 2012
15
13


[Perception of cancer causes and risk, family history and preventive behaviors of users in oncogenetic counseling].
Tiago Barreto de Castro E Silva, Deborah J Macdonald, Victor Evangelista de Faria Ferraz, Lucila Castanheira Nascimento, Cláudia Benedita Dos Santos, Luís Carlos Lopes-Júnior, Milena Flória-Santos. Rev Esc Enferm USP 2013
6
33

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.
Ingrid P Ewald, Patrícia Izetti, Fernando R Vargas, Miguel Am Moreira, Aline S Moreira, Carlos A Moreira-Filho, Danielle R Cunha, Sara Hamaguchi, Suzi A Camey, Aishameriane Schmidt,[...]. Hered Cancer Clin Pract 2011
24
13

Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.
Sonia Garritano, Federica Gemignani, Edenir Inez Palmero, Magali Olivier, Ghyslaine Martel-Planche, Florence Le Calvez-Kelm, Laurence Brugiéres, Fernando Regla Vargas, Ricardo Renzo Brentani, Patricia Ashton-Prolla,[...]. Hum Mutat 2010
84
13

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
Magda C B Gomes, Mauricio M Costa, Radovan Borojevic, Alvaro N A Monteiro, Roberto Vieira, Sergio Koifman, Rosalina Jorge Koifman, Song Li, Robert Royer, Shiyu Zhang,[...]. Breast Cancer Res Treat 2007
55
13

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
Karen H Lu, Marie E Wood, Molly Daniels, Cathy Burke, James Ford, Noah D Kauff, Wendy Kohlmann, Noralane M Lindor, Therese M Mulvey, Linda Robinson,[...]. J Clin Oncol 2014
138
13

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.
Juliana G Assumpção, Ana Luíza Seidinger, Maria José Mastellaro, Raul C Ribeiro, Gerard P Zambetti, Ramapriya Ganti, Kumar Srivastava, Sheila Shurtleff, Deqing Pei, Luiz Carlos Zeferino,[...]. BMC Cancer 2008
64
13

Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil.
Ana Luiza Seidinger, Maria José Mastellaro, Fernanda Paschoal Fortes, Juliana Godoy Assumpção, Izilda Aparecida Cardinalli, Mônica Aparecida Ganazza, Raul Correa Ribeiro, Silvia Regina Brandalise, Simone Dos Santos Aguiar, José Andrés Yunes. Cancer 2011
50
13

Li-fraumeni syndrome.
David Malkin. Genes Cancer 2011
210
13

Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Juliana Giacomazzi, Marcia S Graudenz, Cynthia A B T Osorio, Patricia Koehler-Santos, Edenir I Palmero, Marcelo Zagonel-Oliveira, Rodrigo A D Michelli, Cristovam Scapulatempo Neto, Gabriela C Fernandes, Maria Isabel W S Achatz,[...]. PLoS One 2014
33
13

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
96
13

Nationwide breast cancer screening programme fully implemented in The Netherlands.
J Fracheboud, H J de Koning, R Boer, J H Groenewoud, A L Verbeek, M J Broeders, B M van Ineveld, J H Hendriks, A E de Bruyn, R Holland,[...]. Breast 2001
85
6

The natural history of breast carcinoma: what have we learned from screening?
L Tabár, S W Duffy, B Vitak, H H Chen, T C Prevost. Cancer 1999
223
6

Knowledge, attitude and practice of mammography among women users of public health services.
Luiz Alberto Barcelos Marinho, José Guilherme Cecatti, Maria José Duarte Osis, Maria Salete Costa Gurgel. Rev Saude Publica 2008
17
6




[An analyze the opportunities of early detection of breast cancer].
Luciana Molina, Ivete Dalben, Laurival A de Luca. Rev Assoc Med Bras (1992) 2003
17
6



[Survival study of breast cancer patients treated at the hospital of the Federal University in Santa Maria, Rio Grande do Sul, Brazil].
Anaelena Bragança de Moraes, Roselaine Ruviaro Zanini, Marcelo Scalvenzi Turchiello, João Riboldi, Lídia Rosi de Medeiros. Cad Saude Publica 2006
31
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.